Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-80
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

About this trial

The goal of this observational study is to improve the intraoperative diagnosis accuracy of invasiveness for small-sized lung adenocarcinoma by combining multi-modal information. The main question it aims to answer is whether multi-modal information have great value of prediction on the invasiveness for small-sized lung adenocarcinoma. Since a promising limited resection is largely based on intraoperative frozen section diagnosis, there is a growing demand on the high-accuracy of timely pathology diagnosis. The multi-modal information of participants will be collected retrospectively.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

From January 2018 to December 2022, about 3000 patients with lung adenocarcinoma were enrolled in this retrospective study.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Invasiveness diagnosis

    Diagnostic test

    To predict the invasiveness of patients with small-sized lung adenocarcinoma intraoperatively based on multi-modal information.

Treatment groups

3,000 Participants
are divided into 3 treatment groups
Group A: adenocarcinoma in situ1 intervention
Group B: minimally invasive adenocarcinoma1 intervention
Group C: invasive adenocarcinoma1 intervention

Trial outcomes

Primary outcomes

1

Final pathology diagnosis of the paraffin section stained with HE

The final pathology diagnosis after resection

Time frame
Immediately after operation

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.